Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,888 | 5,340 | 11,065 | 20,613 | 14,166 |
| Receivables | 487 | 66 | 55 | 63 | 146 |
| Other current assets | 516 | 114 | 1,053 | 1,285 | 740 |
| TOTAL | $3,891 | $5,520 | $12,173 | $21,961 | $15,052 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 14,417 | 19,842 | 20,369 | 21,443 | 13,926 |
| TOTAL | $14,417 | $19,842 | $20,369 | $21,443 | $13,926 |
| Total Assets | $18,307 | $25,362 | $32,541 | $43,403 | $28,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 363 | 0 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 2,071 | 2,728 | 4,765 | 3,686 | 1,845 |
| Other current liabilities | 1,237 | 671 | 767 | 2,536 | 144 |
| TOTAL | $3,672 | $3,399 | $5,532 | $6,222 | $1,989 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,423 | 6,584 | 6,535 | 6,711 | 1,430 |
| TOTAL | $7,018 | $8,441 | $8,438 | $8,899 | $3,817 |
| Total Liabilities | $10,689 | $11,840 | $13,970 | $15,121 | $5,806 |
| Shareholders' Equity | |||||
| Common Shares | 59,419 | 61,290 | 58,503 | 59,993 | 52,954 |
| Retained earnings | -54,063 | -49,518 | -41,254 | -33,029 | -30,886 |
| Other shareholders' equity | 2,262 | 1,750 | 1,323 | 1,318 | 1,104 |
| TOTAL | $7,618 | $13,522 | $18,572 | $28,282 | $23,172 |
| Total Liabilities And Equity | $18,307 | $25,362 | $32,542 | $43,403 | $28,978 |